Nominations for the ESCMID Awards are now open. ESCMID honours the contributions made by researchers, clinicians, and other pioneers in the fields of clinical microbiology and infectious diseases through a number of awards no matter the stage in your career. You can see all of the different awards that ESCMID bestows as well as the eligibility criteria for each award on our website. Nominations close in August so be sure to see them now and start your application today!

Science and Research

ESCMID Study Groups can apply for dedicated research funding starting tomorrow 21 May. This special funding opportunity is specific for ESCMID Study Group research projects and only members can apply. Be sure to join an ESCMID Study Group which is free for all members to be able to submit your research project for funding. You can learn more about how to apply on our website. The call closes on 16 July.

Don’t miss these expert insights on post-licensing clinical trials for advancing the use of antimicrobials at this upcoming REVIVE webinar organised by GARDP. Steven Tong will present the SNAP trial for S. Aureus bacteraemia - a scalable, adaptive platform addressing priority clinical questions. Patrick Harris will discuss the challenges of trials for Gram-negative bacteria and how we can rethink trial design to support better access and impact.

Education

In high resistance endemic settings, difficult-to-treat infections are not just clinical challenges - they are urgent public health threats. This ESCMID online course is designed specifically to empower professionals with the knowledge and practical tools to develop and lead antimicrobial stewardship programmes tailored to their local realities. Through this interactive course, participants will gain essential insights and strategies to combat antimicrobial resistance effectively, optimise patient care, and safeguard antibiotic efficacy for the future.

This course is part of the ESCMID AMS Certificate Programme and has a few spots available for extra participants.

Ensure safety at every level of care: this advanced ESCMID course offers healthcare professionals a comprehensive overview of technical hygiene, infection prevention, and occupational safety. Learn how hospital infrastructure - ventilation, water systems, and medical devices - can influence infection risks, and gain practical knowledge on reprocessing, laboratory safety, and biohazard management. The programme includes real-world examples and an exclusive visit to the central reprocessing unit of a leading 2000-bed university hospital. Join us and take the lead in shaping safer, smarter, and infection-resilient healthcare systems.

This course is part of the ESCMID EUCIC IPC Certificate Programme and has a few spots available for extra participants.

Congress and Events

Last chance to submit your late-breaker abstract for the 14th edition of the International Meeting on Microbial Epidemiological Markers (IMMEM XIV). Don’t miss this opportunity to join in the programme, submit your abstract before the deadline on 23 May 2025.

Learn more about the abstract topics that are being accepted and get information on the programme and additional activities on the website.

The abstracts accepted and presented at ESCMID Global 2025 have been collectively published in an official congress abstract book that is now available on our website. The abstract book has also been submitted for a final publication in CMI Communications to allow for all abstracts presented at the congress to be in a citable format. The abstract book will be available on our website until the publication process is complete. Check it out today!

Guidelines and Journals

It’s Communicable’s first birthday! Kicking off the podcast’s second year of life, editors of CMI Comms, Marc Bonten, Josh Davis, Erin McCreary, Emily McDonald, all clinical trialists in their own right, take turns to summarise and discuss late-breaker trials presented at ESCMID Global 2025. The episode covers: the CloCeBa trial, the Taper V trial, the ASTARTÉ trial and others! This is part 1 of a 2-part series, “Late-breaker trials at ESCMID Global: Should they change your practice?”

Bridging the evidence gap: expert consensus on management of SARS-CoV-2 acute infection and post-COVID-19 condition in immunocompromised patients

Selective digestive tract decontamination in the intensive care unit: Life saver or recipe for disaster?